BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 13, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Sept. 24, 2025

Sep. 24, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Angelini, Boehringer Ingelheim, Merck, Sovargen, Tegmine, Variational AI.
Read More

Other news to note for Sept. 23, 2025

Sep. 23, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bracken, Caristo Diagnostics, Compass Bioinformatics, Epic, Genomenon, Labconnect, Myriad, Quest, Sophia Genetics.
Read More

Other news to note for Sept. 23, 2025

Sep. 23, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: C4X, Genfit, Teva.
Read More

Other news to note for Sept. 23, 2025

Sep. 23, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Axceled, Adagene, Austrianova Avant, Biocytogen, Cadrenal, Exelixis, Exithera, Haisco, Kalexo, Klothonova, Kwangdong, Mabwell, Ocugen, Tubulus, Xforest.
Read More

Other news to note for Sept. 22, 2025

Sep. 22, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent Technologies, Astrazeneca, Femasys, Immunovia, Lunit, Medical Electronic Systems, Onconetix, Premier, Sophia Genetics.
Read More

Other news to note for Sept. 22, 2025

Sep. 22, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Alera, Axcelead, Carisma, Orthocellix, Syndax, Xforest.
Read More

Other news to note for Sept. 19, 2025

Sep. 19, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Argá Medtech, Medical Care Technologies, Renalytix, Roche, Tempus AI, True-See, T Rx Capital.
Read More

Other news to note for Sept. 19, 2025

Sep. 19, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Arvinas, Alcyone, Austrianova, Avant, Biocardia, Biogen, Bluebird, Genetix, Klothonova, Infinimmune, Immunome, Novo Nordisk Pfizer, X4.
Read More

Other news to note for Sept. 18, 2025

Sep. 18, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Forcast Orthopedics, Hubly Surgical, Kane Biotech, Koru Medical, Lindus Health, Nano-x Imaging, Nucleobio, Precheck Health, Quest, Sam Medical, Tytek, Siemens Healthineers, Stryker, Whoop.
Read More

Other news to note for Sept. 18, 2025

Sep. 18, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Arch, Frame Bio, Hillevax, Innate, Lipdro, Mercury Bio, Theratechnologies, Tonix, Xoma.
Read More
Previous 1 2 … 30 31 32 33 34 35 36 37 38 … 1402 1403 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing